<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJIM</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>The Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17017671</article-id>
      <article-id pub-id-type="pmc">3890725</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2006.21.3.194</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>High-grade Hepatic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Probably Transformed from the Low-grade Gastric MALT Lymphoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Yong Woo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Sohn</surname>
            <given-names>Joo Hyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paik</surname>
            <given-names>Chang Hee</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeong</surname>
            <given-names>Jae Yoon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Dong Soo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jeon</surname>
            <given-names>Yong Cheol</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oh</surname>
            <given-names>Young Ha</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pathology, Hanyang University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Correspondence to: Joo Hyun Sohn, M.D., Departments of Internal Medicine Hanyang University Guri Hospital, Gyomun-dong 249-1, Guri 471-701, Korea. Tel: 82-31-560-2225, Fax: 82-31-555-2998, <email>sonjh@hanyang.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2006</year>
      </pub-date>
      <volume>21</volume>
      <issue>3</issue>
      <fpage>194</fpage>
      <lpage>198</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>11</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>2</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2006</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The Mucosa-associated lymphoid tissue (MALT) lymphoma, which was first described in 1983, is known to be caused by chronic <italic>Helicobacter pylori</italic> (HP) infection, which triggers lymphoid infiltration and formation of organized lymphoid tissue. In approximately two thirds of cases of MALT, the lymphoma has been observed to regress after treatment of <italic>H. pylori</italic> infection; this provides strong evidence of a causative role of HP in the etiology of MALT. We report a case of a 67-year-old female patient with a high-grade MALT lymphoma of the liver; this occurred six years after complete remission of a low-grade gastric MALT lymphoma and after complete eradication of <italic>H. pylori</italic>. there was no recurrence of the previous low-grade gastric MALT lymphoma. Based on radiological and pathologic findings, the high-grade MALT was considered to result from transformation of the low-grade gastric MALT lymphoma.</p>
      </abstract>
      <kwd-group>
        <kwd>MALT lymphoma</kwd>
        <kwd>High-grade transformation</kwd>
        <kwd>
          <italic>Helicobacter pylori</italic>
        </kwd>
        <kwd>Liver</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>The stomach is one of the most common organs where MALT lymphoma develops. It is well established, that more than 90% of low-grade MALT lymphomas are associated with <italic>H. pylori</italic> infection<xref ref-type="bibr" rid="B1">1)</xref>. Indeed, the eradication of <italic>H. pylori</italic> infection has been associated with the regression of gastric MALT lymphoma in 70% to 80% of patients<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3)</xref>. Additional factors contribute to the development of MALT lymphoma such as: environmental, microbial, immune and genetic factors. Transformation of MALT lymphoma has been described; there is genetic evidence for a clonal link between low- and high-grade components<xref ref-type="bibr" rid="B4">4)</xref>. Here, we report a case of high-grade hepatic MALT lymphoma that occurred six years after achieving complete remission of a low-grade gastric MALT lymphoma with <italic>H. pylori</italic> eradication therapy. There was no recurrence of the low-grade gastric MALT lymphoma itself. Although we were unable to obtain cytogenetic evidence, the radiological and pathologic findings suggested that the low-grade MALT was transformed to a high-grade hepatic MALT lymphoma.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 67-year-old woman visited our hospital with complaints of abdominal discomfort, indigestion and constipation for five days. Physical examination and laboratory findings were not specific, and her performance was excellent. Gastroscopic examination showed an ulcero-infiltrative lesion at the greater curvature side of the antrum (<xref ref-type="fig" rid="F1">Figure 1</xref>). Histological examination revealed mucosal ulceration with diffuse infiltration of lymphoid cells. Diffuse and nodular aggregates of lymphoid cells were composed of monotonous small to medium-sized lymphocytes with round to cleaved nuclei and clear cytoplasm. In some areas, relatively large atypical lymphoid cells were also present in less than 10% of tumor cells. There were a few foci of lymphoepithelial lesions (<xref ref-type="fig" rid="F2">Figure 2</xref>). Immunohistochemical stains were positive for CD20 and CD79a, but negative for CD45RO, CD3, CD5, CD23, Bcl-2 and Cyclin D1. <italic>H. pylori</italic> infection was detected using the rapid urease test and histology. An abdominal CT scan revealed focal wall thickening on the greater curvature side of antrum without any lymph node enlargement. Unfortunately, a bone marrow biopsy was not performed, thus staging work-up of the lymphoma was not fully performed. The patient was diagnosed with a low-grade gastric MALT lymphoma and treated for <italic>H. pylori</italic> infection for 14 days with omeprazole 20 mg bid, clarithromycin 500 mg bid and amoxicillin 1,000 mg bid. Follow-up gastroscopic examinations, one and three months after <italic>H. pylori</italic> eradication, showed marked improvement of gastric lesions. <italic>H. pylori</italic> infection was absent by rapid urease testing and histology, but MALT lymphoma was still present on histology evaluation. Thereafter the patient was lost to follow-up.</p>
      <p>Four years later, the patient visited our hospital again with complaints of indigestion and constipation. Gastroscopy showed diffuse erythematous changes of the antral mucosa with an irregular surface at the site of the previous MALT lymphoma that appeared to be a scar. Gastric mucosal biopsy showed well preserved foveolar epithelium, and sparsely scattered inflammatory cells in the lamina propria devoid of residual lymphoma. <italic>H. pylori</italic> infection was not found using the rapid urease test and by histology. Abdominal CT scan showed neither gastric wall thickening nor lymph node enlargement (<xref ref-type="fig" rid="F3">Figure 3</xref>). These findings were interpreted to represent complete remission of the gastric MALT lymphoma. The patient was then again lost to follow-up.</p>
      <p>About two years later, the patient returned to our hospital with complaints of general weakness and epigastric discomfort. Blood tests on admission showed a hematocrit of 36.1%, a white blood cell count of 4,200/mm<sup>3</sup>, a platelet count of 77,000/mm<sup>3</sup>, a protein of 4.6 g/dL, an albumin of 2.4 g/dL, a total bilirubin of 3.0 mg/dL (0.2-1.0 mg/dL), a direct bilirubin of 2.5 mg/dL (0.0-0.2 mg/dL), an alkaline phosphatase of 588 U/L (32-104 U/L), an alanine aminotransferase of 196 U/L (10-36 U/L), an aspartate aminotransferase of 357 U/L (10-30 U/L), a lactate dehydrogenase of 1,871 U/L (211-423 U/L), and a prothrombin time of 11.8 sec (10-14 sec). Gastroscopic examination showed several round superficial ulcerations and diffuse mucosal erythema at the antrum. Histological examination revealed only chronic inflammation and intestinal metaplasia with the absence of <italic>H. pylori</italic> infection and MALT lymphoma (<xref ref-type="fig" rid="F4">Figure 4</xref>). Abdominal sonography and liver MRI showed multiple hepatic nodules with multiple celiac and para-aortic lymphadenopathy (<xref ref-type="fig" rid="F5">Figure 5</xref>). Ultrasonography-guided percutaneous core needle biopsy was performed on the hepatic nodules; histological examination revealed a patchy infiltration, of atypical lymphoid cells, replacing the liver parenchyma. There were conspicuous medium to large lymphoid cells admixed with monocytoid cells. The composition of the large lymphoid cells, found in the liver biopsy, was significantly increased when compared to the previous gastric MALT lymphoma. Immunohistochemical stains were positive for CD20, but negative for: CD45RO, CD3, CD5, CD23, Bcl-2 and Cyclin D1 (<xref ref-type="fig" rid="F6">Figure 6</xref>). Immunohistochemical stains for Ki-67 were performed both on the biopsy from the previous low-grade gastric MALT lymphoma and the liver core biopsy. The Ki-67 labeling index, from the liver biopsy sample, was much higher (70%) than in the previous gastric biopsy (20%) (<xref ref-type="fig" rid="F7">Figure 7</xref>). These pathological findings suggested a hepatic MALT lymphoma that represented a transformation from the previously treated low-grade gastric MALT lymphoma to a high-grade MALT lymphoma. The patient, and her family, refused further treatment and her clinical status deteriorated rapidly; she died from sepsis one month later.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The MALT lymphoma was first described as a distinct pathologic entity in 1983.<xref ref-type="bibr" rid="B5">5)</xref> In 1988, it became apparent that the gastric MALT lymphoma is caused by chronic <italic>H. pylori</italic> infection; this triggers lymphoid infiltration and formation of organized lymphoid tissue<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7)</xref>. Perhaps the strongest evidence is that in approximately two thirds of cases, the lymphoma regresses after treatment of the <italic>H. pylori</italic> infection<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3)</xref>. It is assumed that the initial proliferation of lymphoma cells occurs in an antigen-dependent fashion; this explains the tendency for these lymphomas to remain anatomically localized and to respond to antibacterial therapy. Given that most patients with H. pylori gastritis do not develop MALT lymphoma, additional events such as environmental, microbial, immune and genetic factors must play an important role<xref ref-type="bibr" rid="B8">8)</xref>. Our patient was positive for <italic>H. pylori</italic> infection; the initial original gastric MALT lymphoma completely disappeared after eradication of <italic>H. pylori</italic> infection. However, the occurrence of transformation to a high-grade lymphoma without evidence of <italic>H. pylori</italic> re-infection strongly suggests that some other pathological mechanisms, besides <italic>H. pylori</italic> infection, played a role in disease progression.</p>
      <p>The understanding of the biology of the gastric MALT lymphoma has improved over the past few years. There is a common structural cytogenetic abnormality associated with this disorder, t(11;18)(q21;q21), detected in 21% to 60% of cases<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B11">11)</xref>. This translocation acts to fuse the inhibitors of apoptosis (IAP) family API2 with the novel gene MALT1. The characterization of another, albeit less frequent recurrent translocation, t(1;14)(p22;q23) has led to the identification of Bcl10<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13)</xref>. Both translocations are known to result in activation of the central transcription factor NF-&#x3BA;B<xref ref-type="bibr" rid="B14">14)</xref>. NF-&#x3BA;B induction appears to drive antigen independent growth of the lymphoma cells, promoting disease dissemination and unresponsiveness to <italic>H. pylori</italic> eradication therapy<xref ref-type="bibr" rid="B8">8)</xref>.</p>
      <p>Transformation of MALT lymphoma has been described, and there is a genetic evidence for a clonal link between low- and high-grade components<xref ref-type="bibr" rid="B4">4)</xref>. Deletion of the p16, mutations of the p53 gene, translocation breakpoint involved in t(6;14)(p21;q32), and Bcl-6 have been described to be associated with transformation of the MALT lymphoma<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17)</xref>. Moreover, numerous investigators have sequenced immunoglobulin heavy chain (IgH) genes, and have found frequent somatic mutations that can be ongoing<xref ref-type="bibr" rid="B18">18)</xref>. Somatic hypermutations, together with isotype switch recombination, contributes to B-cell maturation. Unfortunately, we could not perform cytogenetic evaluations or IgH gene rearrangement analysis in our patient. However, in the pathological findings, the composition of the large lymphoid cells and the expression of the proliferation marker Ki-67 were significantly increased in the hepatic nodules compared to the previous gastric MALT lymphoma; these results suggested that the hepatic nodules represented a transformation to a higher grade malignant lymphoma from the prior low-grade gastric MALT lymphoma. In addition, the occurrence of high-grade transformation, even after complete remission of the original gastric lesion, its aggressive nature may suggest that our patient had one or more underlying cytogenetic abnormalities. However, the possibility that the hepatic MALT lymphoma might be a newly developed and separate lesion, with no relationship to the initial low-grade gastric MALT lymphoma, can not be completely excluded.</p>
      <p>In summary, we report a case of high-grade hepatic MALT lymphoma that occurred six years after achieving complete remission of a low-grade gastric MALT lymphoma. Although we did not perform cytogenetic evaluation, the hepatic MALT lymphoma was considered to represent a transformation from the gastric MALT lymphoma on the basis of radiological and pathological findings. In addition, these findings suggest that the determination of a complete cure for MALT lymphoma based on gastroscopic and histological findings might not be adequate. Regular follow-up, even after complete remission of the original lesion, is mandatory, and cytogenetic studies should be considered in certain cases if available.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wotherspoon</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Ortiz-Hidalgo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Falzon</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma</article-title>
          <source>Lancet</source>
          <year>1991</year>
          <volume>338</volume>
          <fpage>1175</fpage>
          <lpage>1176</lpage>
          <pub-id pub-id-type="pmid">1682595</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bayerdorffer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Neubauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Thiede</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lehn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Eidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stolte</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Regression of primary gastric lymphoma of mucosaassociated lymphoid tissue type after cure of Helicobacter pylori infection</article-title>
          <source>Lancet</source>
          <year>1995</year>
          <volume>345</volume>
          <fpage>1591</fpage>
          <lpage>1594</lpage>
          <pub-id pub-id-type="pmid">7783535</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roggero</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zucca</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pinotti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pascarella</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Capella</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Savio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pedrinis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Paterlini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Venco</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cavalli</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue</article-title>
          <source>Ann Intern Med</source>
          <year>1995</year>
          <volume>122</volume>
          <fpage>767</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="pmid">7717599</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Diss</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma</article-title>
          <source>Histopathology</source>
          <year>1997</year>
          <volume>30</volume>
          <fpage>425</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">9181363</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isaacson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Malignant lymphoma of mucosa-associated lymphoid tissue: a distinct type of B-cell lymphoma</article-title>
          <source>Cancer</source>
          <year>1983</year>
          <volume>52</volume>
          <fpage>1410</fpage>
          <lpage>1416</lpage>
          <pub-id pub-id-type="pmid">6193858</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyatt</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Immune response of the gastric mucosa to Campylobacter pylori</article-title>
          <source>Scand J Gastroenterol Suppl</source>
          <year>1988</year>
          <volume>142</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">3166533</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stolte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eidt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori?</article-title>
          <source>J Clin Pathol</source>
          <year>1989</year>
          <volume>42</volume>
          <fpage>1269</fpage>
          <lpage>1271</lpage>
          <pub-id pub-id-type="pmid">2613920</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahl</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>Update: gastric MALT lymphoma</article-title>
          <source>Curr Opin Oncol</source>
          <year>2003</year>
          <volume>15</volume>
          <fpage>347</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">12960515</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Auer</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Gascoyne</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Connors</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Cotter</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Greiner</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Sanger</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Horsman</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>t(11;18)(q21;q21) is the most common translocation in MALT lymphomas</article-title>
          <source>Ann Oncol</source>
          <year>1997</year>
          <volume>8</volume>
          <fpage>979</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="pmid">9402171</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baens</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maes</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Steyls</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Geboes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Marynen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>de Wolf-Peeters</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>156</volume>
          <fpage>1433</fpage>
          <lpage>1439</lpage>
          <pub-id pub-id-type="pmid">10751367</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ruskone-Fourmestraux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thiede</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lavergne</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boot</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Caletti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wundisch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Taal</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Elena</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zinzani</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Neubauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stolte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hamoudi</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dogan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>MQ</given-names>
            </name>
          </person-group>
          <article-title>t(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication</article-title>
          <source>Gastroenterology</source>
          <year>2002</year>
          <volume>122</volume>
          <fpage>1286</fpage>
          <lpage>1294</lpage>
          <pub-id pub-id-type="pmid">11984515</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willis</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Jadayel</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>MQ</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Abdul-Rauf</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Karran</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Majekodunmi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wlodarska</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hamoudi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Dyer</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types</article-title>
          <source>Cell</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>35</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">9989495</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Siebert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hinzmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rakestraw</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Naeve</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Beckmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Weisenburger</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Sanger</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Nowotny</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vesely</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Callet-Bauchu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Salles</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dixit</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Rosenthal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schlegelberger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)</article-title>
          <source>Nat Genet</source>
          <year>1999</year>
          <volume>22</volume>
          <fpage>63</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">10319863</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucas</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Yonezumi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Inohara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>McAllister-Lucas</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Abazeed</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Yamaoka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Seto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nunez</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>19012</fpage>
          <lpage>19019</lpage>
          <pub-id pub-id-type="pmid">11262391</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neumeister</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hoefler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Beham-Schmid</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Apfelbeck</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schaider</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Linkesch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sill</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas</article-title>
          <source>Gastroenterology</source>
          <year>1997</year>
          <volume>112</volume>
          <fpage>1871</fpage>
          <lpage>1875</lpage>
          <pub-id pub-id-type="pmid">9178679</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue</article-title>
          <source>Am J Pathol</source>
          <year>1996</year>
          <volume>148</volume>
          <fpage>643</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="pmid">8579126</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sonoki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Harder</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Horsman</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Karran</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Gesk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Steinemann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zucca</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schlegelberger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sole</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mungall</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Gascoyne</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Siebert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dyer</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>2837</fpage>
          <lpage>2844</lpage>
          <pub-id pub-id-type="pmid">11675358</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hallas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Greiner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muller-Hermelink</surname>
              <given-names>HK</given-names>
            </name>
          </person-group>
          <article-title>Immunoglobulin VH genes of high-grade mucosa-associated lymphoid tissue lymphomas show a high load of somatic mutations and evidence of antigen-dependent affinity maturation</article-title>
          <source>Lab Invest</source>
          <year>1998</year>
          <volume>78</volume>
          <fpage>277</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">9520941</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Gastroscopy showed ulcero-infiltrative lesions with a hemorrhagic and irregular surface located at the greater curvature side of the antrum.</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>(A) Low power view showed mucosal ulceration with diffuse infiltration of lymphoid cells (H&amp;E, &#xD7;40). (B) High power view showed diffuse infiltration of monotonous centrocyte-like cells and a few large lymphoid cells with a conspicuous lymphoepithelial lesion (arrow), which are highlighted by the cytokeratin immunostain (Inset; Cytokeratin, &#xD7;400) and demonstrate characteristics of MALT lymphoma (H&amp;E, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Abdominal CT scan performed four years after initial presentation showed neither gastric wall thickening nor lymph node enlargement. Moreover, there was no evidence of a hepatic mass.</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4</label>
      <caption>
        <p>Gastric biopsy performed six years later, after initial presentation, showed chronic gastritis with intestinal metaplasia devoid of residual MALT lymphoma (H&amp;E, &#xD7;100)</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g004"/>
    </fig>
    <fig id="F5" position="float">
      <label>Figure 5</label>
      <caption>
        <p>T2 scan of a liver MRI showed multiple hepatic nodules in segments III, IV, VI, VIII (white arrow) with multiple lymphadenopathy (black arrow).</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g005"/>
    </fig>
    <fig id="F6" position="float">
      <label>Figure 6</label>
      <caption>
        <p>(A) Low power view showed patchy infiltration of atypical lymphoid cells replacing liver parenchyma (H&amp;E, &#xD7;40). (B) High power view showed conspicuous large lymphoid cells admixed with monocytoid cells (H&amp;E, &#xD7;400). (C) Tumor cells were diffusely positive for CD20 (CD20, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g006"/>
    </fig>
    <fig id="F7" position="float">
      <label>Figure 7</label>
      <caption>
        <p>Ki-67 labeling index was estimated at about 20% at the initial gastric biopsy (A) and 70% from liver biopsy samples (B) (Ki-67, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjim-21-194-g007"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
